Logo-hpp
2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SNIP(2022):1.389
SJR(2022): 0.78
Platinum
Open Access

Health Promot Perspect. 2023;13(2): 140-146.
doi: 10.34172/hpp.2023.17
PMID: 37600544
PMCID: PMC10439450
  Abstract View: 282
  PDF Download: 261
  Full Text View: 79

Original Article

Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison

Shakir Ullah 1 ORCID logo, Shahbaz Khan 2 ORCID logo, Shahrzad Bazargan-Hejazi 1,3* ORCID logo, Ernesto Ramirez 1, Senait Teklehaimanot 1, Sara Diab 4, Maria Bangash 5, Magda Shaheen 1,3

1 Charles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA
2 Ayub Medical College and Teaching Hospital, Abbottabad, Pakistan
3 Department of Psychiatry, Charles R. Drew University of Medicine and Science and David Geffen School of Medicine, University of California at Los Angeles, CA, USA
4 University of California, Irvine, CA, USA
5 Southern California University of Health and Sciences, CA, USA
*Corresponding Author: Shahrzad Bazargan-Hejazi, Emails: Shahrzadbazargan@ cdrewu.edu, , Email: shahrzadb@ucla.edu

Abstract

Background: Although effective antihypertensive medications have existed for decades, only about half of the hypertensive individuals are considered to have controlled blood pressure. Limited research studies have investigated gender disparity in the utilization and effectiveness of antihypertensive medications treatment. To examine the gender difference in antihypertensive medications’ use and the effect of using antihypertensive medication treatment on blood pressure control among the U.S. adult with hypertension.

Methods: Analysis of National Health and Nutrition Examination Survey (NHANES) data from (1999-2012) including individuals≥18 years old with hypertension. Study variables included gender, age, race/ethnicity, obesity, smoking, comorbidities, treatment medication type, and continuity of care. We used multivariate logistic regression in STATA V14. The data is presented as adjusted odds ratios (ORs) and 95% confidence interval (CI).

Results: Of the 15719 participants, 52% were female. 49% of the antihypertensive medication users had their blood pressure under control (95% CI). In the adjusted logistic regression analysis, use of antihypertensive medications was found to be 12% greater in females as compared to males (OR=1.12; CI=1.02-1.22; P<0.05). No association between gender and blood pressure control was found. Blood pressure control was less likely achieved among 50 years or younger individuals, Blacks and Hispanics, obese, and those taking calcium channel blocker (CCB).

Conclusion: Hypertensive females are more likely than males to use antihypertensive medications. The effectiveness of treatment to control blood pressure is equal across males and females. Our findings have implications for practitioners to account gender-specific approaches when discussing adherence to hypertension medication treatment with their patients.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 283

Your browser does not support the canvas element.


PDF Download: 261

Your browser does not support the canvas element.


Full Text View: 79

Your browser does not support the canvas element.

Submitted: 18 Feb 2023
Revision: 22 Mar 2023
Accepted: 23 Mar 2023
ePublished: 10 Jul 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)